000 06641nam a22006135i 4500
001 978-981-99-5696-8
003 DE-He213
005 20251030111451.0
007 cr nn 008mamaa
008 240228s2024 si | s |||| 0|eng d
020 _a9789819956968
_9978-981-99-5696-8
024 7 _a10.1007/978-981-99-5696-8
_2doi
050 4 _aR850.A1-854
050 4 _aQH315-320
072 7 _aMBGR
_2bicssc
072 7 _aMED106000
_2bisacsh
072 7 _aMBGR
_2thema
245 1 0 _aFungi Bioactive Metabolites
_h[electronic resource] :
_bIntegration of Pharmaceutical Applications /
_cedited by Sunil Kumar Deshmukh, Jacqueline Aparecida Takahashi, Sanjai Saxena.
250 _a1st ed. 2024.
264 1 _aSingapore :
_bSpringer Nature Singapore :
_bImprint: Springer,
_c2024.
300 _aXVII, 762 p. 1 illus.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
505 0 _aPart I: Bioactive Compounds from Endophytic Fungi -- Chapter 1. Recent Advances in Pharmaceutically Important Compounds from Endophytic Fungi -- Chapter 2. Pharmaceutically Important Compound Produced by Endophytic Fungi Having Anti-Infective Activity -- Chapter 3. Fungal Endophytes: An Accessible Natural Repository for Discovery of Bioactive Compounds -- Part II: Endolichenic Fungi: A Source of New Chemical Entities -- Chapter 4. Endolichenic Fungi as a Source of Pharmaceutically Active Compounds -- Chapter 5. Endolichenic Fungi, an Emerging Source of Bioactive Compounds: A Pharmaceutical Perspective -- Part III: Marine Fungi as a Source of Medicinal Compounds -- Chapter 6. Antibiofilm Metabolites from Sponge-derived Aspergillus, Penicillium, and Fusarium for the Antibiotic Pipeline -- Chapter 7. Marine Fungi as a Bioresource of Medicinal Entities -- Chapter 8. Natural Bioactive Products from Marine Fungi against Bacterial Infection. Part IV: Fungi as a Bioresource of Pharmacologically Active Agents -- Chapter 9. Penicillium: A Treasure-Trove for Antimycobacterial and Antioxidant Metabolites -- Chapter 10. Metabolites from Fungi: a Promising Source of Lead Compounds against Cancer -- Chapter 11. Edible Mushrooms Substances as Natural Prevention in Autoimmunological Diseases -- Chapter 12. New Antifungal Drugs: Discovery and Therapeutic Potential -- Chapter 13. Fungal Enzyme Inhibitors: Potent Repository of Lead Compounds to Curb Cancer -- Chapter 14. Bioactive Metabolites from Fungi with Anti-Inflammatory and Anti-Thrombotic Properties; Current Status and Future Perspectives for Drug Development -- Chapter 15. Progress in the Development of Fungal Metabolites as New Drugs for Human Mycoses -- Part V: Fungi from Extremophilic Environment/Unique Ecosystems -- Chapter 16. Uncovering the Desert Fungal Enigma: An Attractive Resource for Biopharmaceuticals -- Chapter 17. Bioactive Metabolites Produced by Fungi Present inAntarctic, Arctic and Alpine Ecosystems -- Part VI: Novel Strategies to Screen or Enhance Secondary Metabolite Production -- Chapter 18. Enhancing Chemical Diversity of Fungal Secondary Metabolite by OSMAC Strategy -- Chapter 19. Epigenetic Regulation of Fungal Secondary Metabolites for the Enhancement of Therapeutically Active Compounds -- Chapter 20. Strategies for Enhancing the Production of Echinocandin -- Part VII: Other by Products of Fungal Metabolism with Medicinal Applications -- Chapter 21. Fungal Pigments: Applications and Their Medicinal Potential -- Chapter 22. A Brief Insight into Peptide and Non-Peptide Drugs of Fungal Origin -- Chapter 23. Kojic Acid from Aspergillus wentii: A Journey from Isolation to Application -- Part VIII: Bioinformatics and Fungal Biotransformations in Pharmaceutical Drug Development -- Chapter 24. How Does Bioinformatics Play a Role in Fungal Drug Discovery? -- Chapter 25. Fungal Biotransformation of Steroids: History, Current Status, and Future Prospects. .
520 _aThis book presents the exploration and exploitation of various bioactive metabolites obtained from fungi isolated from diverse habitats for pharmaceutical applications. Various fungal sources have been brought under one umbrella ranging from endophytes, marine fungi, endolichenic fungi to fungi existing in the extremophilic conditions like desert and Antarctica and Artic environment. The book tries to cover maximally the range of the pharmaceutical applications wherein these bioactive agents from fungi have been exploited or are in the clinical pipelines and primarily include antibacterial, antifungal, antibiofilm, anticancer, antioxidant, autoimmunological, anti-inflammatory, and anti-thrombotic diseases. The book further emphasizes on the novel strategies to screen or enhance secondary metabolite production. Some other topics includes peptides, nonpeptides drugs, pigments, and enhancement of production of Echinocandin and Kojic acid. The role of bioinformatics in drug discovery and biotransformations have also been discussed. This book is going to be a comprehensive treatise and a valuable source for mycologists, biotechnologists, microbiologists, biotechnologists, and undertaking research in pharmaceutical sector as well as academia in setting up their research aspirations for using fungi in the process of drug discovery and development. .
650 0 _aMedicine
_xResearch.
_962598
650 0 _aBiology
_xResearch.
_965629
650 0 _aDrug delivery systems.
650 0 _aMolecular biology.
650 0 _aMolecular ecology.
_972017
650 0 _aCytology.
_967436
650 1 4 _aBiomedical Research.
_965633
650 2 4 _aDrug Delivery.
_969429
650 2 4 _aMolecular Biology.
650 2 4 _aMolecular Ecology.
_972018
650 2 4 _aCell Biology.
_967440
700 1 _aDeshmukh, Sunil Kumar.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_972019
700 1 _aTakahashi, Jacqueline Aparecida.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_972020
700 1 _aSaxena, Sanjai.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_972021
710 2 _aSpringerLink (Online service)
773 0 _tSpringer Nature eBook
776 0 8 _iPrinted edition:
_z9789819956951
776 0 8 _iPrinted edition:
_z9789819956975
776 0 8 _iPrinted edition:
_z9789819956982
856 4 0 _uhttps://doi.org/10.1007/978-981-99-5696-8
912 _aZDB-2-SBL
912 _aZDB-2-SXB
999 _c57975
_d57975